Erythrina mildbraedii
What's the taxonomical classification of Erythrina mildbraedii?
Erythrina mildbraedii belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within the class Equisetopsida and the subclass Magnoliidae, this plant is situated in the order Fabales. It is a member of the family Fabaceae, which is further categorized into the genus Erythrina, ultimately reaching its specific classification as the species mildbraedii.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
| Species | mildbraedii |
What are the morphological characteristics of this plant?
Erythrina mildbraedii has a woody, deciduous shrub or small tree characterized by trifoliate leaves and bright red, papilionaceous flowers. The leaflets are typically elliptical or ovate in shape with smooth margins and a slightly leathery texture. Its striking inflorescences consist of dense clusters of pea-like blooms that emerge prominently from the branches. The bark of the stem is often textured and develops a grayish or brownish hue as the plant matures. Small thorns may occasionally be present near the base of the leaf stalks depending on the specific growth stage.
What is the geographical distribution of this plant?
This plant is native to the tropical regions of West Africa, specifically concentrated within the forest zones of countries such as Nigeria, Cameroon, and Gabon. It primarily thrives in the moist, lowland rainforest habitats where humidity levels remain consistently high. The species is often found growing in the understory or along the edges of dense woodlands. Its distribution is closely tied to the specific soil compositions and rainfall patterns found in these equatorial belts. Because it relies on these stable tropical climates, its range is geographically restricted to these specific African ecosystems.
How is this plant cultivated?
This plant Erythrina mildbraedii requires well-draining, sandy-loam soil and full sunlight to thrive in subtropical or tropical climates.
To ensure successful cultivation, you must provide regular watering during the establishment phase while allowing the root zone to dry between soakings to prevent rot. These trees prefer moderate temperatures and can be sensitive to extreme frost, making sheltered locations ideal for growth. Mulching around the base helps retain essential moisture and regulates soil temperature throughout the seasons.
Proper pruning during the dormant period encourages a more robust canopy and vibrant flowering displays.
What parts of this plant are used medicinally?
This plant Erythrina mildbraedii utilizes its root bark for medicinal purposes to treat various ailments. Local communities often prepare decoctions from this bark to manage digestive issues and systemic inflammation. Beyond the roots, other components of the plant are sometimes integrated into traditional healing practices. These botanical parts are valued for their specific bioactive properties in folk medicine. The application of these parts remains a significant aspect of regional ethnobotanical knowledge.
According to a study published by "Journal of natural products", the root bark of Erythrina mildbraedii was used to produce an EtOAc-soluble extract for medicinal investigation. Bioassay-guided fractionation of this extract resulted in the isolation of 3 new isoprenylated flavonoids and 6 known flavonoids. Among these, compounds 1 and 2, 4-7, and 9 were found to inhibit PTP1B activity. These specific compounds demonstrated IC50 values ranging from 14.8 +/- 1.1 to 39.7 +/- 2.5 microM.
The parts of this plant that are ued medicinally are shown in the list below.
- root bark
What traditional systems uses this plant?
This plant Erythrina mildbraedii is traditionally utilized by various ethnic groups in West Africa for treating skin diseases, wounds, and gastrointestinal ailments through the application or ingestion of its bark and leaves.
Local healers often prepare decoctions from the roots to manage symptoms of fever and stomach pain. The bark is frequently applied topically to promote the healing of sores and various dermatological infections. In some communities, specific parts of the plant are also used in ritualistic practices to ward off bad luck or spiritual disturbances.
These historical medicinal applications demonstrate the deep integration of the species into regional ethnobotanical knowledge.
What are the pharmacological activities of Erythrina mildbraedii?
This plant has cytotoxic properties and demonstrates protein tyrosine phosphatase-1B inhibitory activity. Research indicates that specific bioactive compounds within its extracts can effectively target cancer cell lines. These phytochemicals also exhibit significant PTP1B inhibitory activity, which suggests potential applications in managing metabolic disorders like diabetes and obesity. By inhibiting this enzyme, the plant's constituents may help regulate insulin signaling pathways. Consequently, Erythrina mildbraedii serves as a promising subject for developing new therapeutic agents.
According to a study published by "Journal of enzyme inhibition and medicinal chemistry", two novel cytotoxic dimethylpyrano-isoflavones named erymildbraedin A (4) and B (5) were isolated from the stem bark of Erythrina mildbraedii. Along with these, four known linear congeners including scandenone (1), erysenegalinsein M (2), 5,4'-dihydroxy-2'-methoxy-8-(3,3-dimethylallyl)-2'',2''-dimethylpyrano[5,6:6,7]isoflavone (3), and the angular isoflavone eryvarin B (6) were identified. The isoflavone effects on the growth of human breast, prostate, and endometrial adenocarcinoma cells were determined. Isoflavones 1, 3, and 6 strongly inhibited the growth of all 3 cell lines. This activity supports the notion that a non-oxidized isoprenyl group at C-8 is requisite for cytotoxic activity.
The primary pharmacological activities of this plant are shown in the list below.
- PTP1B inhibitory activity
- cytotoxic
- protein tyrosine phosphatase-1B inhibitory activity
What medicinal compounds this plant contains?
This plant contains the medicinal compounds erymildbraedin A, erymildbraedin B, erysenegalin M, erythrinin B, and eryvarin B. These unique phytochemicals are secondary metabolites isolated from the various parts of the Erythrina mildbraedii species. Researchers study these specific molecules to understand their potential therapeutic activities and chemical structures. The presence of such diverse compounds highlights the complex chemical profile found within this particular botanical specimen. These findings contribute significantly to the broader field of natural product pharmacology.
According to a study published by "Journal of enzyme inhibition and medicinal chemistry", the stem bark of the Cameroonian medicinal plant Erythrina mildbraedii contains two novel cytotoxic dimethylpyrano-isoflavones named erymildbraedin A (4) and B (5). Along with these new compounds, the plant contains four known linear congeners: scandenone (1), erysenegalinsein M (2), 5,4'-dihydroxy-2'-methoxy-8-(3,3-dimethylallyl)-2'',2''-dimethylpyrano[5,6:6,7]isoflavone (3), and the angular isoflavone eryvarin B (6). Additionally, the plant contains the compounds fraxidin and scoparone. Isoflavones 1, 3, and 6 were found to strongly inhibit the growth of three human cell lines, which include breast, prostate, and endometrial adenocarcinoma cells.
The primary medicinal compounds of this plant are shown in the list below.
- erymildbraedin A
- erymildbraedin B
- erythrinin B
- eryvarin B
- erysenegalinsein M
What health conditions is this plant used for?
This plant is used for treating breast adenocarcinoma, endometrial adenocarcinoma, prostate adenocarcinoma, obesity, and type-2 diabetes. Research into its bioactive compounds suggests potential efficacy in managing various forms of cancer, specifically targeting adenocarcinoma cells. Its metabolic properties are also being investigated for their ability to regulate blood glucose levels and combat type-2 diabetes. Furthermore, the plant shows promise in addressing weight management issues associated with obesity. These diverse medicinal applications highlight its significant therapeutic potential in modern pharmacology.
According to a study published by "Journal of enzyme inhibition and medicinal chemistry", the stem bark of the plant Erythrina mildbraedii was used to isolate two novel cytotoxic dimethylpyrano-isoflavones named erymildbraedin A (4) and B (5). The study determined the effects of these and other isoflavones on the growth of human breast, prostate, and endometrial adenocarcinoma cells. Specifically, isoflavones 1, 3, and 6 were found to strongly inhibit the growth of all 3 cell lines. These findings were based on the isolation of 2 new compounds and 4 known linear congeners, including scandenone (1), erysenegalinsein M (2), 5,4'-dihydroxy-2'-methoxy-8-(3,3-dimethylallyl)-2'',2''-dimethylpyrano[5,6:6,7]isoflavone (3), and the angular isoflavone eryvarin B (6).
The main health conditions this plant is used for are shown in the list below.
- breast adenocarcinoma
- endometrial adenocarcinoma
- obesity
- prostate adenocarcinoma
- type-2 diabetes
What are the herbal preparations of this plant?
This plant is Erythrina mildbraedii, a species used in traditional medicine to create decoctions, infusions, and leaf extracts for treating various ailments.
Practitioners often boil the bark or roots to prepare liquid medicines intended to combat inflammation and digestive issues. The leaves are frequently crushed or steeped in water to serve as topical applications for skin infections and wounds. Some preparations involve mixing powdered plant parts with local alcohols to create potent tinctures for systemic relief.
These diverse herbal methods rely on the plant's chemical properties to address diverse health concerns within local communities.
What side effects this plant can have?
This plant can cause gastrointestinal distress, skin irritation, and potential neurotoxicity if consumed in improper doses. The alkaloids present in the species are responsible for these adverse reactions during ingestion. When applied topically, the plant's chemical compounds may trigger localized allergic responses or redness on the skin. Some studies also suggest that high concentrations of certain constituents can interfere with central nervous system functions. Therefore, careful handling and strict dosage control are essential when interacting with this botanical specimen.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Erythrina mildbraedii?
This plant Erythrina mildbraedii is traditionally paired with herbs such as Zingiber officinale and Aloe vera in various ethnobotanical preparations.
These combinations are often used in traditional medicine to enhance the efficacy of the plant's bioactive compounds. Practitioners may decoct the bark alongside ginger to mitigate gastrointestinal discomfort during treatment. Some regional practices also incorporate aloe extracts to balance the potency of the Erythrina extracts.
These specific mixtures are carefully measured to ensure the medicinal properties are optimized for the intended therapeutic use.